Bioethics Blogs

From the Director: PRIM&R’s Comments in Response to OHRP’s and FDA’s Draft Guidance on IRB Written Procedures

PRIM&R submitted comments to the Department of Health and Human Services’ (DHHS) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) in response to their jointly released draft guidance on institutional review board (IRB) written procedures. The guidance is “intended for…IRBs and institutions responsible for review and oversight of human subject research under the HHS or FDA regulations, or both.”

The post From the Director: PRIM&R’s Comments in Response to OHRP’s and FDA’s Draft Guidance on IRB Written Procedures appeared first on Ampersand.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.